NCT02679742View on ClinicalTrials.gov

Postacute Sarcopenia: Supplementation With β-hydroxyMethylbutyrate After Resistance Training

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

February 6, 2021

Study Completion Date

February 6, 2021

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

β-hydroxymethylbutyrate

β-hydroxymethylbutyrate 3 grams once a day combined with a resistance training program (3 progressive resistance training sessions per week) during 12 weeks

DIETARY_SUPPLEMENT

Placebo

Maltodextrin 3 grams once a day combined with a resistance training program (3 progressive resistance training sessions per week) during 12 weeks

Trial Locations (1)

09024

Hospital de l'Esperanza, Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT02679742 - Postacute Sarcopenia: Supplementation With β-hydroxyMethylbutyrate After Resistance Training | Biotech Hunter | Biotech Hunter